ES2536526T3 - Método para diagnóstico - Google Patents

Método para diagnóstico Download PDF

Info

Publication number
ES2536526T3
ES2536526T3 ES11738258.0T ES11738258T ES2536526T3 ES 2536526 T3 ES2536526 T3 ES 2536526T3 ES 11738258 T ES11738258 T ES 11738258T ES 2536526 T3 ES2536526 T3 ES 2536526T3
Authority
ES
Spain
Prior art keywords
tau
concentration
individual
disease
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11738258.0T
Other languages
English (en)
Inventor
Omar El-Agnaf
Lucilla Parnetti
Paolo Calabresi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Arab Emirates University
UNI DEGLI STUDI PERUGIA
Universita degli Studi di Perugia
Original Assignee
United Arab Emirates University
UNI DEGLI STUDI PERUGIA
Universita degli Studi di Perugia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Arab Emirates University, UNI DEGLI STUDI PERUGIA, Universita degli Studi di Perugia filed Critical United Arab Emirates University
Application granted granted Critical
Publication of ES2536526T3 publication Critical patent/ES2536526T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un metodo para identificar si un individuo tiene o no Enfermedad de Parkinson (PD) en lugar de una enfermedad neurodegenerativa que no es PD seleccionada entre Enfermedad de Alzheimer (AD), Demencia con cuerpos de Lewy (DLB) y Demencia Frontotemporal (FTD), comprendiendo dicho metodo: (i) medir la concentracion de α-sinucleina (α-sin) en una muestra de fluido cefalorraquideo (CSF) obtenida del individuo; (ii) medir la concentracion de tau sin fosforilar (tau) y / o fosforilada (p-tau) presente en la muestra; y (iii) calcular la relacion de:**Fórmula** en la que la concentracion total de tau es la concentracion acumulativa de p-tau y tau medida en la muestra; y (iv) determinar de ese modo si el individuo tiene PD o no.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
ES11738258.0T 2010-07-06 2011-07-06 Método para diagnóstico Active ES2536526T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1011420.5A GB201011420D0 (en) 2010-07-06 2010-07-06 Method for diagnosis
GB201011420 2010-07-06
PCT/GB2011/001026 WO2012004566A1 (en) 2010-07-06 2011-07-06 Method for diagnosis

Publications (1)

Publication Number Publication Date
ES2536526T3 true ES2536526T3 (es) 2015-05-26

Family

ID=42669301

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11738258.0T Active ES2536526T3 (es) 2010-07-06 2011-07-06 Método para diagnóstico

Country Status (5)

Country Link
US (1) US8778334B2 (es)
EP (1) EP2591367B1 (es)
ES (1) ES2536526T3 (es)
GB (1) GB201011420D0 (es)
WO (1) WO2012004566A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013003350A2 (en) 2011-06-27 2013-01-03 Eisai R&D Management Co., Ltd. Microrna biomarkers indicative of alzheimer's disease
WO2014059052A1 (en) * 2012-10-09 2014-04-17 Uab Research Foundation Methods and compositions for diagnosis and treatment of parkinson's disease and parkinsonism
US11238984B2 (en) * 2015-04-24 2022-02-01 Honor Technology, Inc. Systems and methods for ensuring quality of care services
JP6273338B1 (ja) * 2016-12-05 2018-01-31 磁量生技股▲ふん▼有限公司 パーキンソン病からパーキンソン病認知症を特定する方法
EP3873496A4 (en) * 2018-11-04 2022-11-09 Figene, LLC TREATMENT OF BRAIN HYPOXIA INCLUDING STROKE, CHRONIC TRAUMATIC ENCEPHALOPATHY AND TRAUMATIC BRAIN INJURY
CN112402418B (zh) * 2020-12-16 2022-03-01 安徽中烟工业有限责任公司 一种单胺氧化酶b(mao-b)抑制剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312349T1 (de) * 1998-07-03 2005-12-15 Innogenetics Nv Differentielle diagnose von neurodegeneration
DK1886112T3 (da) * 2005-04-06 2014-09-08 Univ St Louis Fremgangsmåde til Måling af metabolismen af neuralt afledte biomolekyler in vivo
SI2154969T1 (sl) * 2007-05-16 2016-02-29 The Brigham And Women's Hospital, Inc. Zdravljenje sinukleinopatij
WO2009152607A1 (en) * 2008-06-16 2009-12-23 Ottawa Hospital Research Institute Methods and kits for diagnosing neurodegenerative disease
US20120190652A1 (en) * 2009-09-16 2012-07-26 United Arab Emirates University Diagnostic agent for parkinson's disease

Also Published As

Publication number Publication date
EP2591367B1 (en) 2015-02-25
EP2591367A1 (en) 2013-05-15
US8778334B2 (en) 2014-07-15
WO2012004566A1 (en) 2012-01-12
US20130183278A1 (en) 2013-07-18
GB201011420D0 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
ES2536526T3 (es) Método para diagnóstico
BR112017004357A2 (pt) métodos e aparelhos de supressão de ruído
PH12016500046A1 (en) System and method for identifying and authenticating a tag
MY161291A (en) Antibody, kit and method for determination of amyloid peptides
BR112017003724A2 (pt) calibração de sensores de corrente por meio de uma corrente de referência durante a medição de corrente
JP2015511014A5 (es)
SG10201803294PA (en) Tau imaging probe
ES2540255A1 (es) Método de aislamiento de cuerpos apoptóticos
BR112018010266A2 (pt) lactoferrina para uso no diagnóstico ou prognóstico da doença de alzheimer ou no diagnóstico da doença de parkinson
BR112014005130A2 (pt) método e sistema para recalibragem de sensor
MX2018016279A (es) Compuestos para formacion de imagenes de agregados de proteinas tau.
CO2019000087A2 (es) Procedimiento de análisis de residuos / heparinas y sus derivados por resonancia magnética nuclear
FR3086527B1 (fr) Capteur pour mesurer un potentiel biologique
FR3007390B1 (fr) Mecanisme de verrouillage d'un capot d'aeronef integrant un capteur pour detecter l'etat non verrouille du capot
BR112017005243A2 (pt) "detecção de disfunção com considerações biológicas"
WO2015068075A3 (en) Detection of tau
ES2448941B1 (es) Método y sistema de alarma para detectar posturas incorrectas
BR112017005246A2 (pt) detecção de disfunção
BR112013031048A2 (pt) método de adaptação de um composto de assinatura de um fenótipo que é derivado a partir de medições da amostra; aparelho de imagem clínica para a adaptação de uma assinatura composta de um fenótipo que é derivado de medições de uma amostra; elemento do programa para a adaptação de uma assinatura composta de um fenótipo; meio de leitura por computador
ES2518690B1 (es) Método para la detección de áreas anómalas en el cerebro a partir de imágenes de resonancia magnética
ES1135017U (es) Instrumento de medición para determinar un punto de medición anatómica
ES2539399B2 (es) Método de medida para un sensor saturable
TR201901544T4 (tr) Serebrospi̇nal sividaki̇ albümi̇n redoks sevi̇yesi̇ baz alinarak alzheimer hastaliğina yöneli̇k i̇n vi̇tro tani yöntemi̇
ES2608712A2 (es) Dispositivo de medición dimensional
RU2013151981A (ru) Способ определения типа психики индивидуума